Clostridioides difficile-related toxic megacolon after Cryptococcus neoformans cellulitis: A complex of two rare infections in an immunocompromised host. Issue 5 (May 2019)
- Record Type:
- Journal Article
- Title:
- Clostridioides difficile-related toxic megacolon after Cryptococcus neoformans cellulitis: A complex of two rare infections in an immunocompromised host. Issue 5 (May 2019)
- Main Title:
- Clostridioides difficile-related toxic megacolon after Cryptococcus neoformans cellulitis: A complex of two rare infections in an immunocompromised host
- Authors:
- Koizumi, Yusuke
Kachi, Asako
Tsuboi, Kenji
Muto, Jun
Watanabe, Hiroki
Asai, Nobuhiro
Nobata, Hironobu
Shiota, Arufumi
Kato, Hideo
Sakanashi, Daisuke
Hagihara, Mao
Yamagishi, Yuka
Suematsu, Hiroyuki
Banno, Shogo
Mikamo, Hiroshige - Abstract:
- Abstract: A 76-year-old Japanese woman was admitted due to uncontrolled cellulitis of the right lower leg. She had deep vein thrombosis on the right limb. Moreover, she had a long history of rheumatoid arthritis treated with corticosteroids. Skin biopsy and lumbar puncture were performed to diagnose disseminated cryptococcosis. She was administered antifungal agents (liposomal amphotericin B and 5-fluorocytosine). On treatment day 14, debridement was performed, and cryptococcosis was controlled. However, she developed toxic megacolon due to Clostridioides difficile infection (CDI). On day 32, she was transferred to the intensive care unit due to severe acidosis and acute kidney injury secondary to CDI-related toxic megacolon. Vancomycin, metronidazole, and tigecycline were administered for treatment of CDI. After several weeks of intensive care, toxic megacolon was improved, but renal replacement therapy was discontinued according to the patient's will. On day 73, she died of renal failure. We experienced a complex of rare diseases, Cryptococcus neoformans cellulitis and Clostridioides difficile -related toxic megacolon. Both diseases were presumed to be the result of corticosteroid and methotrexate use. Hence, careful monitoring is required when treating immunocompromised hosts to reduce the risk of developing complications.
- Is Part Of:
- Journal of infection and chemotherapy. Volume 25:Issue 5(2019:May)
- Journal:
- Journal of infection and chemotherapy
- Issue:
- Volume 25:Issue 5(2019:May)
- Issue Display:
- Volume 25, Issue 5 (2019)
- Year:
- 2019
- Volume:
- 25
- Issue:
- 5
- Issue Sort Value:
- 2019-0025-0005-0000
- Page Start:
- 379
- Page End:
- 384
- Publication Date:
- 2019-05
- Subjects:
- Acute renal failure -- Immunocompromised host -- Meningitis -- Prednisolone -- Cutaneous ulcer -- Tigecycline
Chemotherapy -- Periodicals
Infection -- Periodicals
Communicable diseases -- Chemotherapy -- Periodicals
615.5805 - Journal URLs:
- http://www.sciencedirect.com/science/journal/1341321X ↗
http://link.springer-ny.com/link/service/journals/10156/index.htm ↗
http://www.springerlink.com/content/1341-321x ↗
http://www.elsevier.com/journals ↗
http://firstsearch.oclc.org ↗ - DOI:
- 10.1016/j.jiac.2018.12.003 ↗
- Languages:
- English
- ISSNs:
- 1341-321X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5006.691000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 9858.xml